-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-knee-update-disposition-archived.pdf
May 04, 2017 - similar outcome (e.g., VAS
and WOMAC pain measures), as two
tools used in the same study on the
same participant … topics/osteoarthritis-knee-update/research-2017/
Published Online: May 4, 2017
18
#4 the <50 participant
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_vulnerable_populations_kreps.ppt
May 29, 2025 - No Slide Title
Communicating Harm and Benefits to Vulnerable Populations
Gary L. Kreps, Ph.D.
Mandell Professor of Health Communication and Chair
Department of Communication
George Mason University
gkreps@gmu.edu
Vulnerable populations in need of relevant health information
Elderly
Socio-economically deprive…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
June 16, 2010 - Were the participant characteristics similar at baseline in the study groups
compared?
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
July 31, 2024 - Disposition of Comments_Comparative Effectiveness Review No. 271, Treatments for Maternal Mental Health Conditions
Comparative Effectiveness Review Disposition of Comments Report
Title: Nonpharmacologic Treatments for Maternal Mental Health Conditions
Draft report available for simultaneous peer review…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
May 01, 2015 - able to be extracted from data in the papers
Data must be presented in the aggregate (vs. individual-participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
January 01, 2016 - able to be abstracted from data in the papers
Data must be presented in the aggregate (vs. individual participant
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/data-repository-reviews_white-paper.pdf
September 01, 2012 - Proposed Governance and Data Management Policy for the Systematic Review Data Repository
Research White Paper
Proposed Governance and Data Management Policy
for the Systematic Review Data Repository
Research White P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide_executive.pdf
April 01, 2007 - Layout 1
User’s Guide to
Registries Evaluating
Patient Outcomes:
Summary
Advancing Excellence in Health Care • www.ahrq.gov
Agency for Healthcare Research and Quality
The Effective Health Care Program of the Agency for Healthcare Research and Quality (AHRQ) conducts and
supports research focused on…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
April 01, 2010 - Table 1
The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of
AHRQ’s Effective Health Care Program. It is a collaborative network of research centers that
support the rapid development of new scientific information and analytic tools. The DEcIDE
network assists health ca…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-257-antenatal-care-disposition-comments.pdf
June 28, 2022 - Disposition of Comments_Comparative Effectiveness Review No. 257_Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review
Comparative Effectiveness Review Disposition of Comments Report
Title: Schedule of Visits and Televisits for Routine Antenatal Care: A Systematic Review
…
-
effectivehealthcare.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
February 01, 2008 - description of study outcomes, blinding
of outcome assessors, intent-to-treat analysis, description of participant … Observational studies will be assessed for sample size, participant selection method,
exposure measurement
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ankyloglossia_research-protocol.pdf
June 30, 2014 - Data must be presented in the aggregate (vs. individual participant … We anticipate that these data will include those
related to baseline participant characteristics (age
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
February 01, 2008 - description of study outcomes, blinding
of outcome assessors, intent-to-treat analysis, description of participant … Observational studies will be assessed for sample size, participant selection method,
exposure measurement
-
effectivehealthcare.ahrq.gov/sites/default/files/ebc-challenge-webinar-transcript.pdf
June 01, 2014 - Female Participant. We see a lot of strep throat. … Female Participant. That is a great question and of course that would be key.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_research-protocol.pdf
February 01, 2008 - outcomes, blinding of subjects, blinding of outcome assessors, intent-to-treat analysis,
description of participant … Observational studies will
be assessed for sample size, participant selection method, exposure measurement
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_11-user-guide-to-ocer_130129.pdf
January 03, 2012 - A classic
example is an “intention to treat” analysis that
assumes that each participant continues … statement is used to
invoke robust confidence intervals (as there is only
one subject for each unique participant
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_research-protocol.pdf
December 23, 2014 - control characteristics (intervention
components, timing, frequency, and duration), followup duration, participant … (Appendix B)
We selected items most relevant in assessing risk of bias for this topic, including
participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
August 01, 2013 - methylprednisolone
versus placebo,22 vardenafil versus placebo,23 and
Deanxit versus placebo (with each participant … Note: Deanxit comparison is a crossover trial of Deanxit vs. placebo, with each participant given 1 mg
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
May 19, 2020 - information on general study characteristics
(e.g., study design, study period, and follow-up), study participant
-
effectivehealthcare.ahrq.gov/sites/default/files/oct_13_webinar_transript_10-13-11.pdf
October 13, 2011 - language of
science, but it enables advocates to take a seat the table
and to engage as an active participant